Blog > Archive by tag 'biotech'

Tag: biotech

 

The TFN Complete Guide to Biotech Penny Stocks

Published on July 24, 2009

In the course of our research to find the best biotech penny stocks, we compiled a list of all viable companies trading for less than $5 on U.S. exchanges. We appreciate that many of our TFN readers like to do their own analysis and hope this will prove a useful tool…
by The TFN Team
The following [...]

Posted by Laura Cadden · Filed Under Featuring..., Investment Research, Investment Strategies, Politics, US Stocks and Markets | 5 Comments 

Best Options Play: Leverage FDA approval in this $2.55 stock into potential 300% options gains

Published on March 19, 2009

A tiny medical microcap stock expects FDA approval on Monday. Using options to leverage to expected upward momentum could result in 300% gains!
by J. Christoph Amberger
Baltimore—TFN: “The major indexes may be well into negative territory,” writes TFN’s options oracle Andrew Snyder in his internal brief: “But the action won’t bring a frown to the face [...]

Posted by J. Christoph Amberger · Filed Under Options | Leave a Comment 

Best Stock to buy: This MRSA-related stock is a strong buy at current prices!

Published on March 17, 2009

MRSA infections are on the rise. So are lawsuits against prison systems and healthcare providers. Good news for one small biotech company that just landed a MAJOR approval.
by J. Christoph Amberger
Baltimore—TFN: We predicted this in January. Infections with the dangerous Methicillin-resistant Staphylococcus aureus, or MRSA, are fast becoming the next cash cow for litigation lawyers.
According to [...]

Posted by J. Christoph Amberger · Filed Under US Stocks and Markets | 1 Comment 

Biotech mutual funds: A safe way to beat the market?

Published on February 19, 2009

The biotech sector is hot. Many investors want to get in on the action but are too timid to make the plunge. A strong biotech mutual fund is exactly what they need.
By Andrew Snyder, TodaysFinancialNews.com
Baltimore – (TFN): I have mixed feelings about mutual funds. On one hand, they are expensive, bland and often do [...]

Posted by Andrew Snyder · Filed Under Featuring..., Investment Strategies | 1 Comment 

A good lesson from the biotech sector

Published on February 9, 2009

Shares of ViroPharma (NASDAQ:VPHM) are plunging by as much as 50% today because of bad news out of a clinical trial. Investors that owned the shares without a protective strategy are out of luck. But the folks smart enough to protect their investment with options are up as much as 400%.
By Andrew Snyder, TodaysFinancialNews.com
Baltimore [...]

Posted by Andrew Snyder · Filed Under Options | Leave a Comment 

An up and coming biotech: Human Genome Sciences Inc. (HGSI)

Published on February 4, 2009

A lucrative government contract is just one of the things this small cap has going for it.

Posted by Laura Cadden · Filed Under Editor's Pic | Leave a Comment 

Buying biotech: Indevus (IDEV) is making big gains

Published on September 26, 2008

Indevus Pharmaceuticals (NASDAQ:IDEV) is up by over 100% today. The big gains come thanks to positive news from the FDA and company executives signing a great business deal with Teva Pharmaceutical (NASDAQ:TEVA). As the Wall Street mess is cleaned up, we will be seeing more winners just like this.
By Andrew Snyder
Baltimore – (TFN): The [...]

Posted by Andrew Snyder · Filed Under US Stocks and Markets | Leave a Comment 

Buy these funds and ETFs to profit from the biotech merger boom

Published on August 22, 2008

“There have been a mass of deals in the U.S., while on this side of the Atlantic, a number of attractive little biotech stocks have been approached or agreed to bids in the last couple of months.” — John Stepek
Blogger’s note: You probably heard about the $43 billion Roche (RHHBY:OTC) bid [...]

Posted by John Stepek · Filed Under International Investing | Leave a Comment 

Profit from the Biotech Boom

Published on August 7, 2008

“Biotechs offer investors with opportunities to get in on breakthrough technologies, while they are still in the lab… So why have investors stopped investing in these ground-floor companies?” — Jim Nelson
Blogger’s note: Pharmaceutical companies are a well-known haven during a recession. The logic being that, while people may cut back on a [...]

Posted by TFN-US · Filed Under US Stocks and Markets | Leave a Comment 

TFN Hot Stock Pick of Week Video: A diamond in a mud pit

Published on April 3, 2008

Baltimore — (TFN): After the fire sale of Bear Stearns to JPMorgan, the take-over prices of other distressed banks seem to be up for renegotiation. TFN President J. Christoph Ambergers revisits two likely candidates.
Click here to watch the financial video and find out more.
Read this TFN Research Report.
****Make sure you sign [...]

Posted by TFN · Filed Under Featured Video, Videos | Leave a Comment 

Profit Opportunity: A diamond in a mud pit

Published on April 2, 2008

A Today’s Financial News Research Report:
“Invest in the nation’s essential goods and services and your money will be protected against inflation and will still be working towards making you rich.” – Andrew Snyder
By Andrew Snyder, TodaysFinancialNews.com

Today’s Financial News feed provides an independent and practical perspective on the U.S. and global investment markets.
[...]

Posted by Andrew Snyder · Filed Under Hot Stock Pick of the Week | 1 Comment 

Biotech Investment: Where to turn in a stock market crash

Published on February 21, 2008

“As all of us have learned the hard way, if you’re not looking in the right place it can be almost impossible to find winners. That’s why today we’ll turn our attention to a sector that didn’t just survive every recession in the U.S. over the past two decades… [...]

Posted by Andrew Mickey · Filed Under US Stocks and Markets | Leave a Comment